Traders should assess whether the company can secure near-term financing or partnerships to alleviate going concern risks; watch for upcoming cash burn disclosures, equity offerings, or strategic announcements. Stock may face downward pressure due to solvency concerns.
Price Chart
Executive Summary
Oragenics issued a press release to comply with NYSE American rules, confirming that its audited financial statements for 2025 include a going concern qualification due to doubts about its ability to continue as a going concern. This is not a new financial filing but a required disclosure of an existing audit opinion.
Key Facts
- Audited financial statements for year ended December 31, 2025 contain a going concern explanatory paragraph.
- Disclosure made to comply with NYSE American LLC Company Guide Section 610(b).
- No change to previously filed Form 10-K; this is a procedural announcement, not a new financial event.
- Company remains clinical-stage with lead candidate ONP-002 in Phase IIa development for mTBI.
- Market cap is $3M, indicating extreme financial distress or high risk of dilution/closure.
Financial Impact
Material risk to company survival; implies insufficient cash to fund operations without financing, dilution, or restructuring.
Risk Factors
- Risk of delisting if minimum listing standards are not met.
- High likelihood of future dilution or bankruptcy if unable to raise capital.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3262664 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 5w ago | 8-K | $0.5000 $0.4469 | ▼ −10.62% | ▼ −13.80% | $0.4000 (−20.00%) |
Aug 28, 2026 8w ago | 8-K | $0.5098 $0.4800 | ▲ +5.85% | ▲ +5.66% | $0.4000 (+21.54%) |
May 20, 2026 22w ago | DEFA14A | $0.5900 $0.5882 | ▼ −0.31% | ▼ −0.64% | $0.4000 (−32.20%) |
May 19, 2026 22w ago | 8-K | $0.5700 $0.6100 | ▲ +7.02% | ▲ +6.03% | $0.4000 (−29.82%) |
May 7, 2026 24w ago | 8-K | $0.6100 $0.6100 | · 0.00% | ▼ −3.14% | $0.4000 (−34.43%) |
Apr 13, 2026 28w ago | 8-K | $0.6800 $0.5600 | ▼ −17.65% | ▼ −25.38% | $0.4000 (−41.18%) |
Mar 25, 2026 30w ago | Press Release | $0.5800 $0.6400 | ▼ −10.34% | ▲ +0.32% | $0.4000 (+31.03%) |
Mar 23, 2026 31w ago | EFFECT | $0.6800 $0.6600 | ▼ −2.94% | ▼ −10.36% | $0.4000 (−41.18%) |
Mar 11, 2026 32w ago | 8-K | $0.9600 $0.6000 | ▼ −37.50% | ▼ −39.48% | $0.4000 (−58.33%) |
Mar 11, 2026 32w ago | Press Release | $0.8800 $0.6200 | ▼ −29.55% | ▼ −30.07% | $0.4000 (−54.55%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers